My dream vacation involves travelling to a less-visited country, discovering a national park or historical site ... adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys ...

SRPT belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Sarepta Therapeutics Inc is $12.42B. A total of 0.51 million ...

In a report released yesterday, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price target of $210.00. Don't Miss ...

Analyst Luke Sergott of Barclays maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report), with a price target of $209.00. Don't Miss our Black Friday Offers: Luke Sergott has ...

CAMBRIDGE, Mass., October 31, 2024--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on October 31 ...

Sarepta Therapeutics (SRPT) reported $467.17 million in revenue for the quarter ended September 2024, representing a year-over-year increase of 40.8%. EPS of $0.62 for the same period compares to ...

In June, the FDA expanded its approval of Sarepta Therapeutics’ Elevidys gene therapy for Duchenne muscular dystrophy to all patients ages four and older. The one-time treatment (which costs $3. ...

I spent four crazy years writing about Cassava Sciences, Adam Feuerstein writes. Yesterday, the story ended exactly as many ...

In this article, we are going to take a look at where Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stands against other high growth large cap stocks. BlackRock highlighted that its portfolio managers ...

Barclays raised the firm’s price target on Sarepta (SRPT) to $209 from $203 and keeps an Overweight rating on the shares. The company reported a big Q3 beat on both total and Elevidys revenue ...

Cantor Fitzgerald analyst Kristen Kluska upgraded Sarepta (SRPT) to Overweight from Neutral with a price target of $167, up from $152. The company reported Q3 earnings, the first full quarter ...

In downtown Los Angeles, parking lots are often placeholders, eventually giving rise to future development, but in the district known as South Park, one parking lot might just stay low.